title: Postoperative Radiotherapy in Completely Resected Stage II and III Thymoma: How to Translate the Potential Survival Benefit in the Setting of the Future Adoption of the IASLC-ITMIG TNM-Based Staging System.
authors.affiliation: University Hospital, Rouen, France.
authors.forename: Clémence
authors.initials: C
authors.lastname: Basse
authors.affiliation: Institute of Oncology, Hospices Civils de Lyon, Lyon, France.
authors.forename: Claire
authors.initials: C
authors.lastname: Merveilleux du Vignaux
authors.affiliation: Institute of Oncology, Hospices Civils de Lyon, Lyon, France. Electronic address: nicolas.girard@chu-lyon.fr.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Girard
mesh_terms: D005544:Forecasting; D006801:Humans; D008175:Lung Neoplasms; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D013945:Thymoma; D013953:Thymus Neoplasms